{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:15:18Z","timestamp":1760296518581},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[1999,4,9]],"date-time":"1999-04-09T00:00:00Z","timestamp":923616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1038\/sj.bjc.6690372","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:05:46Z","timestamp":1031151946000},"page":"412-418","source":"Crossref","is-referenced-by-count":18,"title":["Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapy"],"prefix":"10.1038","volume":"80","author":[{"given":"T","family":"Sigsgaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Herrstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L J","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Havsteen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S W","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-G","family":"Kj\u00e6rb\u00f8l","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Dombernowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,4,9]]},"reference":[{"key":"BF6690372_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0277-5379(91)90545-O","volume":"27","author":"MS Aapro","year":"1991","unstructured":"Aapro, M. S. (1991). Controling emesis related to cancer therapy. Eur J Cancer 27: 356\u2013361.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR2","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1177\/106002809502901211","volume":"29","author":"VR Adams","year":"1995","unstructured":"Adams, V. R. & Valley, A. W. (1995). Granisetron: the second serotonin-receptor antagonist. Ann Pharmacother 29: 1240\u20131251.","journal-title":"Ann Pharmacother"},{"key":"BF6690372_CR3","first-page":"113","volume-title":"Emesis in Anticancer Therapy","author":"PLR Andrews","year":"1993","unstructured":"Andrews, P. L. R. & Davis, C. J. (1993). The mechanism of emesis induced by anticancer therapies. In Emesis in Anticancer Therapy, 1st Edn, Andrews PLA and Sanger GJ (eds), pp. 113\u2013161. Chapman & Hall: London"},{"key":"BF6690372_CR4","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/0959-8049(92)90631-B","volume":"28A","author":"HG Blijham","year":"1992","unstructured":"Blijham, H. G. (1992). Does granisetron remain effective over multiple cycles? Eur J Cancer 28A: S17\u2013S21.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR5","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1200\/JCO.1990.8.6.1063","volume":"8","author":"J Bonneterre","year":"1990","unstructured":"Bonneterre, J., Chevallier, B., Metz, R., Fargeot, P., Pujade-Laurine, E., Spielmann, M., Tubiana-Hulin, M., Paes, D. & Bons, J. (1990). A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. J Clin Oncol 8: 1063\u20131069.","journal-title":"J Clin Oncol"},{"key":"BF6690372_CR6","first-page":"25","volume":"85","author":"E Campora","year":"1994","unstructured":"Campora, E., Simoni, C. & Rosso, R. (1994). Tropisetron verso ondansetron nella preventione e controllo dell\u00e9mesi in pazienti sottoposte a chemioterapia con FAC\/FEC per carcinoma mammario metastatico o operato. Minerva Med 85: 25\u201331.","journal-title":"Minerva Med"},{"key":"BF6690372_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/j.1875-9114.1986.tb03465.x","volume":"6","author":"RJ Cersosimo","year":"1986","unstructured":"Cersosimo, R. J. & Karp, D. D. (1986). Adrenal corticosteroids as antiemetics during cancer chemotherapy. Pharmacotherapy 6: 118\u2013127.","journal-title":"Pharmacotherapy"},{"key":"BF6690372_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/00000421-198706000-00021","volume":"10","author":"S Chiara","year":"1987","unstructured":"Chiara, S., Campora, E., Lionetto, R., Bruzzi, P. & Rosso, R. (1987). Methylprednisolone for the control of CMF-induced emesis. Am J Clin Oncol 10: 264\u2013267.","journal-title":"Am J Clin Oncol"},{"key":"BF6690372_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000227174","volume":"50","author":"M Clavel","year":"1993","unstructured":"Clavel, M., Soukop, M. & Greenstreet, Y. L. A. (1993). Improved control of emesis and quality of life with ondansetron in breast cancer. Oncology 50: 180\u2013183.","journal-title":"Oncology"},{"key":"BF6690372_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/0277-5379(91)90286-M","volume":"27","author":"RE Coleman","year":"1991","unstructured":"Coleman, R. E., Twelves, C. J., O\u2019Reilly, S. M., Rubens, R. D., Richards, M. A. & Harper, P. G. (1991). Influence of dexamethasone dose on the control of chemotherapy-induced nausea and vomiting. Eur J Cancer 27: 1062\u20131063.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR11","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1002\/1097-0142(19930615)71:12<4043::AID-CNCR2820711239>3.0.CO;2-A","volume":"71","author":"M de Wet","year":"1993","unstructured":"de Wet, M., Falkson, G. & Rapoport, L. (1993). Repeated use of granisetron in patients receiving cytostatic agents. Cancer 71: 4043\u20134049.","journal-title":"Cancer"},{"key":"BF6690372_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1200\/JCO.1996.14.2.644","volume":"14","author":"R De Wit","year":"1996","unstructured":"De Wit, R., Schmitz, P. I. M., Verweij, J., De Boer-Dennart, M., De Mulder, P. H. M., Planting, A. S. T., Van Der Burg, M. E. L. & Stoter, G. (1996). Analysis of cumultative probabilities shows that the efficacy of 5-HT3 antagonist prophylaxis is not maintained. J Clin Oncol 14: 644\u2013651.","journal-title":"J Clin Oncol"},{"key":"BF6690372_CR13","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992). Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71\u201385.","DOI":"10.1016\/0140-6736(92)90997-H"},{"key":"BF6690372_CR14","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/1097-0142(19941001)74:7<1945::AID-CNCR2820740720>3.0.CO;2-C","volume":"74","author":"V Gebbia","year":"1994","unstructured":"Gebbia, V., Cannata, G., Testa, A., Curto, G., Valenza, R., Cipolla, C., Latteri, M. A. & Gebbia, N. (1994). Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting. Cancer 74: 1945\u20131952.","journal-title":"Cancer"},{"key":"BF6690372_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00686319","volume":"30","author":"E Gez","year":"1992","unstructured":"Gez, E., Strauss, N., Vitzhaki, N., Cass, Y. & Edelmann, D. Z. (1992). Methylprednisolone as antiemetic treatment in breast-cancer patients receiving cyclophosphamide, methotrexate, and 5-fluorouracil: a prospective, crossover, randomized blind study comparing two different dose schedules. Cancer Chemother Pharmacol 30: 229\u2013232.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF6690372_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00001813-199607000-00008","volume":"7","author":"H Havsteen","year":"1996","unstructured":"Havsteen, H. & Kj\u00e6r, M. (1996). Antiemetic treatment with two different doses of methylprednisolone in breast cancer patients: a double-blind randomized cross-over study with evaluation of efficacy parameters. Anti-Cancer Drugs 7: 535\u2013542.","journal-title":"Anti-Cancer Drugs"},{"key":"BF6690372_CR17","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1056\/NEJM199304153281502","volume":"328","author":"J Herrstedt","year":"1993","unstructured":"Herrstedt, J., Sigsgaard, T., Boesgaard, M., Jensen, T. P. & Dombernowsky, P. (1993). Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 328: 1076\u20131080.","journal-title":"N Engl J Med"},{"key":"BF6690372_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/BF01681960","volume":"5","author":"J Herrstedt","year":"1997","unstructured":"Herrstedt, J., Sigsgaard, T., Angelo, H. R., Kampmann, J. P. & Hansen, M. (1997). Dose-finding study of oral metopimazine. Support Care Cancer 5: 38\u201343.","journal-title":"Support Care Cancer"},{"key":"BF6690372_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0277-5379(86)90392-5","volume":"22","author":"EM Ibrahim","year":"1986","unstructured":"Ibrahim, E. M., Al-Idrissi, H. Y., Ibrahim, A., Absood, G., Al-Dossary, E., Al-Jammaa, A., Al-Ethan, S. & Eliopoulos, A. (1986). Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with high-dose metoclopramide in patients receiving cancer chemotherapy. Eur J Cancer Clin Oncol 22: 283\u2013288.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF6690372_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/030006057800600311","volume":"6","author":"L Israel","year":"1978","unstructured":"Israel, L. & Rodary, C. (1978). Treatment of nausea and vomiting related to anti-cancerous multiple combination chemotherapy: results of two controlled studies. J Int Med Res 6: 235\u2013240.","journal-title":"J Int Med Res"},{"key":"BF6690372_CR21","unstructured":"Italian Group for Antiemetic Research (1994). Cisplatin-induced delayed emesis: pattern and prognostic factors during three subsequent cycles. Ann Oncol 5: 585\u2013589."},{"key":"BF6690372_CR22","doi-asserted-by":"crossref","unstructured":"Italian Group for Antiemetic Research (1995a). Persistence of efficacy of three antiemetic regimens and prognostic factors in patients undergoing moderately emetogenic chemotherapy. J Clin Oncol 13: 2417\u20132426.","DOI":"10.1200\/JCO.1995.13.9.2417"},{"key":"BF6690372_CR23","doi-asserted-by":"crossref","unstructured":"Italian Group for Antiemetic Research (1995b). Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer. N Engl J Med 332: 1\u20135.","DOI":"10.1056\/NEJM199501053320101"},{"key":"BF6690372_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0140-6736(91)90554-3","volume":"338","author":"A Jones","year":"1991","unstructured":"Jones, A., Hill, A. S., Soukop, M., Hutcheon, A. W., Cassidy, J., Kaye, S. B., Sikora, K., Carney, D. N. & Cunningham, D. (1991). Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet 338: 483\u2013487.","journal-title":"Lancet"},{"key":"BF6690372_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0277-5379(90)90227-K","volume":"26","author":"S Kaasa","year":"1990","unstructured":"Kaasa, S., Kval\u00f8y, S., Dicato, M. A., Ries, F., Huys, J. V., Royer, E. & Carruthers, L. (1990). A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind study. Eur J Cancer 26: 311\u2013314.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR26","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1200\/JCO.1994.12.5.1050","volume":"12","author":"L Kaizer","year":"1994","unstructured":"Kaizer, L., Warr, D., Hoskins, P., Latreille, J., Lofters, W., Yau, J., Palmer, M., Zee, B., Levy, M. & Pater, J. (1994). Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12: 1050\u20131057.","journal-title":"J Clin Oncol"},{"key":"BF6690372_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/oxfordjournals.annonc.a010483","volume":"7","author":"WH Koo","year":"1996","unstructured":"Koo, W. H. & Ang, P. T. (1996). Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy. Ann Oncol 7: 71\u201374.","journal-title":"Ann Oncol"},{"key":"BF6690372_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1200\/JCO.1989.7.1.108","volume":"7","author":"MG Kris","year":"1989","unstructured":"Kris, M. G., Gralla, R. J., Tyson, L. B., Clark, R. A., Cirrincione, C. & Groshen, S. (1989). Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 7: 108\u2013114.","journal-title":"J Clin Oncol"},{"key":"BF6690372_CR29","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1056\/NEJM199304153281503","volume":"328","author":"M Levitt","year":"1993","unstructured":"Levitt, M., Warr, D., Yelle, L., Rayner, H. L., Lofters, W. S., Perrault, D. J., Wilson, K. S., Latreille, J., Potvin, M., Warner, E., Pritchard, K. I., Palmer, M., Zee, B. & Pater, J. L. (1993). Ondansetron compared with dexamethasone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. N Engl J Med 328: 1081\u20131084.","journal-title":"N Engl J Med"},{"key":"BF6690372_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJM198408303110901","volume":"311","author":"M Markman","year":"1984","unstructured":"Markman, M., Sheidler, V., Ettinger, D. S., Quaskey, S. A. & Mellits, E. D. (1984). Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med 311: 549\u2013552.","journal-title":"N Engl J Med"},{"key":"BF6690372_CR31","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0277-5379(91)90311-Z","volume":"27","author":"NW Marschner","year":"1991","unstructured":"Marschner, N. W., Adler, M., Nagel, G. A., Christmann, D., Fenzl, E. & Upadhyaya, B. (1991). Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubucin and cyclophosphamide. Eur J Cancer 27: 1137\u20131140.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0959-8049(05)80069-3","volume":"28","author":"M Martin","year":"1992","unstructured":"Martin, M., Diaz-Rubio, E., Casado, A., Dominguez, S. & Sastra, J. (1992). Progressive loss of antiemetic efficacy during subsequent courses of chemotherapy. Eur J Cancer 28: 430\u2013432.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR33","first-page":"S28","volume":"26","author":"M Marty","year":"1990","unstructured":"Marty, M. (1990). A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard enti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. Eur J Cancer 26: S28\u2013S32.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR34","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/bjc.1996.38","volume":"73","author":"K Matsui","year":"1996","unstructured":"Matsui, K., Fukuoka, M., Takada, M., Kusunoki, Y., Yana, T., Tamura, K., Yoshida, T., Iida, K., Hirashima, T., Tsukada, H., Ushijima, S., Miyawaki, H. & Masuda, N. (1996). Randomized trial for the prevention of delayed emesis in patients receiving high-dose cisplatin. Br J Cancer 73: 217\u2013221.","journal-title":"Br J Cancer"},{"key":"BF6690372_CR35","first-page":"283","volume":"13","author":"CG Moertel","year":"1973","unstructured":"Moertel, C. G. & Reitemeier, R. J. (1973). Controlled studies of metopimazine for the treatment of nausea and vomiting. J Clin Pharmacol 13: 283\u2013287.","journal-title":"J Clin Pharmacol"},{"key":"BF6690372_CR36","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/0959-8049(92)90515-4","volume":"28A","author":"I Moreno","year":"1992","unstructured":"Moreno, I., Rosell, R., Abad, A., Barnadas, A., Carles, J., Ribelles, N., Solano, V. & Font, A. (1992). Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer 28A: 1344\u20131347.","journal-title":"Eur J Cancer"},{"key":"BF6690372_CR37","first-page":"23","volume":"18","author":"K M\u00fcnstedt","year":"1995","unstructured":"M\u00fcnstedt, K., Milch, W., Blaunth-Eckmeyer, E., Sp\u00e4nle, A., Vahrson, H. & Reimer, C. (1995). Prevention of cisplatinum-induced delayed emesis and nausea. Onkologie 18: 23\u201326.","journal-title":"Onkologie"},{"key":"BF6690372_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1200\/JCO.1998.16.2.754","volume":"16","author":"EA Perez","year":"1998","unstructured":"Perez, E. A., Hesketh, P., Sandbach, J., Reeves, J., Chawla, S., Markman, M., Hainsworth, J., Bushnell, W. & Friedman, C. (1998). Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study. J Clin Oncol 16: 754\u2013760.","journal-title":"J Clin Oncol"},{"key":"BF6690372_CR39","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/00000421-198912000-00014","volume":"12","author":"CF Pollera","year":"1989","unstructured":"Pollera, C. F., Nardi, M., Marolla, P., Pinnaro, P., Terzoli, E. & Giannarelli, D. (1989). Effective control of CMF-related emesis with high-dose dexamethasone: results of a double-blind crossover trial with metoclopramide and placebo. Am J Clin Oncol 12: 524\u2013529.","journal-title":"Am J Clin Oncol"},{"key":"BF6690372_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000226638","volume":"45","author":"F Roila","year":"1988","unstructured":"Roila, F., Basurto, C., Minotti, V., Ballatori, E., Tonato, M. & Del Favero, A. (1988). Methylprednisolone versus metoclopramide for prevention of nausea and vomiting in breast cancer patients treated with intravenous cyclophosphamide methotrexate 5-fluorouracil: a double-blind randomized study. Oncology 45: 346\u2013349.","journal-title":"Oncology"},{"key":"BF6690372_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/00000421-199106000-00010","volume":"14","author":"F Roila","year":"1991","unstructured":"Roila, F., Boschetti, E., Tonato, M., Basurto, C., Bracarda, S., Picciafuoco, M., Patoia, L., Santi, E., Penza, O., Ballatori, E. & Del Favero, A. (1991). Predictive factors of delayed emesis in cisplatin-treated patients and antiemetic activity and tolerability of metoclopramide or dexamethasone. Am J Clin Oncol 14: 238\u2013242.","journal-title":"Am J Clin Oncol"},{"key":"BF6690372_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF01358881","volume":"4","author":"RR Silva","year":"1996","unstructured":"Silva, R. R., Bascioni, R., Giorgi, F., Acito, L., De Signoribus, G., Marcellini, M., Menichetti, E. T. & Giuliodori, L. (1996). Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy. Support Care Cancer 4: 287\u2013290.","journal-title":"Support Care Cancer"},{"key":"BF6690372_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000227060","volume":"49","author":"M Soukop","year":"1992","unstructured":"Soukop, M., McQuade, B., Hunter, E., Stewart, A., Kaye, S., Cassidy, J., Kerr, D., Khanna, S., Smyth, J., Coleman, R., Cunningham, D., Powels, T., Davidson, N., Hutcheon, A., Green, J., Slater, A., Rustin, G. & Carney, D. (1992). Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 49: 295\u2013304.","journal-title":"Oncology"},{"key":"BF6690372_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000227458","volume":"52","author":"A Stewart","year":"1995","unstructured":"Stewart, A., McQuade, B., Cronje, J. D. E., Goedhals, L., Gudgeon, A., Corette, L., Froger, X., Tubiana-Hulin, M., Laplaige, P., Roberts, J. T., Mcrae, J., Forster, J., Parasuraman, T. V. & Butcher, M. (1995). Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: A multicenter, double-blind, double-dummy, randomised parallel-group study. Oncology 52: 202\u2013210.","journal-title":"Oncology"},{"key":"BF6690372_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/oxfordjournals.annonc.a057871","volume":"2","author":"M Tonato","year":"1991","unstructured":"Tonato, M., Roila, F. & Del Favero, A. (1991). Methodology of antiemetic trials: A review. Ann Oncol 2: 107\u2013114.","journal-title":"Ann Oncol"},{"key":"BF6690372_CR46","first-page":"286 (Abstract)","volume":"7","author":"C Vallejo","year":"1988","unstructured":"Vallejo, C., Rabinovich, M., Leone, B. & Gonzalez, J. (1988). Toxicity and dose-response of intravenous (i.v.) metopimazine (MPZ) as preventive of high-dose cisplatin (CDDP)-induced emesis. Proc Am Soc Clin Oncol 7: 286 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6690372_CR47","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jnci\/83.16.1169","volume":"83","author":"D Warr","year":"1991","unstructured":"Warr, D., Willan, A., Fine, S., Wilson, K., Davis, A., Erlichman, C., Rusthoven, J., Lofters, W., Osoba, D., Laberge, F., Latreille, J. & Pater, J. (1991). Superiority of granisetron to dexamethasone plus pro0chlorperazine in the prevention of chemotherapy-induced emesis. J Natl Cancer Inst 83: 1169\u20131173.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690372_CR48","unstructured":"World Health Organisation (1979). Handbook for Reporting Results of Cancer Treatment. World Health Organisation: Bask"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690372","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:52:55Z","timestamp":1684414375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,9]]},"references-count":48,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["BF6690372"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690372","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,9]]}}}